Iridex Corporation's Q1 2026 Earnings Call: A Mixed Bag for Medical Device Investors The latest earnings call from Iridex Corporation has provided insight into the company's performance in the first quarter of 2026.
Revenue growth was driven by strong domestic adoption of G Probes and the G6 platform, but there are also signs of challenges facing the industry.
Iridex has made significant strides in operational efficiency improvements by relocating General and Administrative functions out of California, resulting in cost savings of around $100,000 during the first quarter.